There is a moment in the andrology lab that I have never stopped thinking about. You have been at the microscope for the better part of an hour, working through a difficult sample, and then you find them. Two, maybe three living sperm. In a sample the report will call "virtually azoospermic," there they are, moving.
What happens next depends entirely on the laboratory you are standing in.
In some labs, those sperm get individually picked up, protected, and frozen for the day this couple needs them. In others, the conversation drifts, sometimes that same week, toward donor semen. Not because the man has nothing. Because keeping what he has is difficult.
During my time working in IVF laboratories, I rarely saw sperm vitrification performed. Conventional semen freezing, everyone knew. But the moment a sample was low-count or "difficult," donor semen entered the discussion quickly. And I kept asking myself the same question: is donor being suggested because the patient has genuinely run out of options, or because preserving a handful of sperm takes time, skill and effort that nobody wants to spend?
Donor semen is a legitimate and sometimes necessary option. I have written about that before and I will stand by it. But it removes the intended father's genetic link to his child, permanently, for that treatment. A decision of that weight should sit on biology, not on laboratory convenience.
So let me explain the technology that makes the difference, because most patients have never heard of it, and honestly, plenty of people working in this field have never done it.
Freezing versus turning to glass
Everyone knows sperm can be frozen. Samples sit in liquid nitrogen at around minus 196 degrees Celsius and stay usable for years. In conventional freezing, the sample cools gradually, often over liquid nitrogen vapour, before storage.
Vitrification is a different idea. The word means turning a liquid into a glass-like state. Instead of cooling slowly, you cool an extremely small volume so fast that water never gets the chance to organise into ice crystals. Ice is the enemy here. Crystals shred membranes.
Here is what surprises people who know oocyte and embryo vitrification: sperm protocols often work on a completely different logic. Many skip the high concentrations of permeating cryoprotectants entirely. Instead they rely on tiny volumes, very rapid cooling and warming, non-permeating sugars like sucrose or trehalose, some protein in the medium, and specialised carriers built to hold a few sperm, sometimes literally one.
So no, sperm vitrification is not "normal freezing, but faster." The volume, the medium, the carrier, the cooling distance, the warming temperature, the recovery step, every one of these has to be controlled. It is a discipline of its own.
Why the cold hurts
Sperm carry less internal water than eggs or embryos, which makes them tougher against some kinds of cryoinjury. Tougher is not immune. Freezing and warming can cost progressive motility, damage the plasma membrane and acrosome, disturb the mitochondria, raise oxidative stress, trigger apoptotic pathways, and in some cases injure the DNA itself. Post-thaw motility is routinely much lower than what you started with.
But here is the distinction that matters clinically, and it is one I wish more patients were told. Survival, motility, fertilisation, pregnancy and live birth are different outcomes. A sperm can come out of vitrification alive but barely moving, and still be perfectly usable for ICSI, where the embryologist injects a single selected sperm directly into the egg. For a couple with almost nothing, "alive and injectable" is the bar. Not "swimming like a fresh sample."
What it actually involves
The short version. The sample, whether ejaculated or surgically retrieved, is searched. When numbers are very low, individual viable sperm are picked up one at a time with an ICSI pipette. They go into a tiny drop of medium, often with sucrose rather than glycerol, since glycerol can cause osmotic stress and toxicity if concentration and timing are not tightly controlled.
Then the drop is loaded onto a carrier. This is where the engineering lives: Cryotop, Cell Sleeper, cryoloops, capillary tubes, micro-straws, closed microvolume devices, even carriers designed around a single spermatozoon. The carrier matters enormously, because a conventional straw is built for millions of sperm. Freeze three sperm in a standard straw and good luck finding them again after warming.
Cooling is ultrarapid. Warming is just as critical, done fast into warm medium, because slow warming lets microscopic ice nuclei grow back through recrystallisation. Then the sperm are located, washed, assessed, and used.
Time, patience, micromanipulation skill, witnessing at every step. That is the price. Now look at what it buys.
The numbers
The early Cryotop work on individually selected sperm reported recovery around 90 percent for ejaculated and 95 percent for testicular sperm, with post-warming motility around 44 and 42 percent respectively. The same group found sucrose clearly outperforming glycerol for survival, roughly 65 percent against 37. The Cell Sleeper came later, a closed vial with an internal tray, designed to make finding your few sperm after warming less of a treasure hunt.
Then the clinical results started arriving. A 2022 report described fertilisation, pregnancies and healthy babies from individually vitrified sperm recovered from both Cryotop and Cell Sleeper devices. A 2023 study of a closed Cryotop Vial system, no permeating cryoprotectants, no post-warming centrifugation, showed better preserved motility and viability than the comparison methods and lower DNA fragmentation than rapid freezing. A 2025 clinical study vitrified testicular and epididymal sperm in a closed, cryoprotectant-free system and found no statistically significant differences from fresh samples across several outcomes, though results were weaker in the most compromised sample group.
And then the one that convinces me this is no longer a curiosity: a five-year experience published in 2026, covering 434 men with severe oligozoospermia, cryptozoospermia or non-obstructive azoospermia, using a self-designed closed straw for individually selected sperm. High recovery for both ejaculated and testicular sperm, and ten healthy babies born. Case reports have grown into structured clinical programmes.
I am careful with these figures. They come from specific centres, specific carriers, specific hands. Nobody should read them as guaranteed rates. But nobody should pretend this is experimental fantasy either.
Who this is actually for
The value of sperm vitrification is highest when every single sperm counts. The man with severe oligozoospermia, where bulk-freezing the sample means losing what little exists. The cryptozoospermic patient whose sperm appear only after extended centrifugation and searching, where banking across several collections means the treatment does not hinge on what he produces on retrieval day. The man with non-obstructive azoospermia whose testicular biopsy yields a handful of sperm, where freezing them may spare him another surgery. Samples from PESA, TESA, TESE and micro-TESE. Men whose semen quality is visibly declining. Men about to start chemotherapy or radiotherapy. And the case every embryologist knows: the day you unexpectedly find a few sperm after a long search, and the right move is to protect them before the moment passes.
Is it always the better method? No.
A systematic review and meta-analysis did find better post-thaw total and progressive motility with vitrification than conventional freezing, but the included studies used different protocols on different kinds of samples, and the authors declined to crown a universal winner. Rightly so.
For a normal sample with millions of motile sperm, validated conventional freezing is simple and it works. Vitrification earns its place at the other end of the spectrum, where conventional bulk freezing quietly loses sperm at every step: dilution, centrifugation, transfer, searching. The point is not to replace every freezer protocol in the country. The point is that for the right patient, an alternative exists, and not offering it should be a decision, not an accident.
The limitation nobody writes on the report
Here is the paragraph this whole piece exists for.
Preserving a few sperm is genuinely hard. It needs hours at the microscope, micromanipulation skill, proper witnessing, and a validated system. I understand every laboratory that finds it demanding. What I do not accept is difficulty being quietly translated into impossibility when the couple is counselled.
There is a difference between following a routine and practising clinical embryology. A technician can execute a protocol. An embryologist is supposed to know why each step exists, what the alternatives are, and how to adapt safely when the case in front of them is not the case in the manual. The job is not to select the easiest sample to work with. The job is to protect the patient's best scientifically reasonable chance of a child that is genetically theirs.
So before donor semen is put on the table, a few questions deserve honest answers. Has collection been repeated, on different days? Has anyone banked across multiple samples? Was the microscopic search actually extended, or abandoned at the routine mark? Has surgical retrieval been considered? Could the sperm that do exist be individually cryopreserved for ICSI?
Donor semen is the right answer when no usable sperm can be recovered, when repeated retrievals have failed, when a serious genetic disorder is at stake, when it is medically inappropriate to use the partner's sperm, or when a couple simply chooses it with full information. Every one of those is legitimate. What is not legitimate is presenting a technically demanding possibility to a couple as though it were biologically impossible.
One caution before anyone gets inspired
No laboratory should start this by photocopying a protocol from a paper. Before offering it clinically, a lab needs a written and validated procedure, clear inclusion criteria, its own internal recovery and survival data, watertight identification and witnessing, aseptic handling, competency assessment for the people doing it, a plan for storage failure, full traceability, and honest patient counselling. A brilliant recovery rate in a published centre proves what is achievable, not what your lab achieves. Validation is what turns an interesting technique into a responsible service.
The point
Not every preserved sperm survives. Not every survivor fertilises. Not every embryo becomes a baby. Nobody should promise otherwise.
But when a man still has even a few living sperm, the question of whose child this will be deserves more than a shrug at the microscope. Before we replace a man's sperm with a donor's, we should be certain we are facing a limitation of biology, and not a limitation of willingness.
Sources
Kagalwala S. Sperm vitrification. In: Allahbadia G, Kuwayama M, Gandhi G, editors. Vitrification in Assisted Reproduction: A User's Manual. Springer India; 2015. pp. 31–42.
Endo Y, et al. Single spermatozoon freezing using Cryotop. Journal of Mammalian Ova Research. 2011;28:47–52.
Endo Y, et al. Simple vitrification for small numbers of human spermatozoa. Reproductive BioMedicine Online. 2012;24(3):301–307.
Endo Y, Fujii Y, Motoyama H. Clinical and neonatal outcomes of individually vitrified human sperm with Cryotop and Cell Sleeper. Cryobiology. 2022;108:78–81.
Bagheripour N, et al. A new Cryotop Vial device system provides an aseptic, cryoprotectant-free and centrifuge-free cryopreservation of human spermatozoa. Cryobiology. 2023;111:70–75.
Kuznyetsova I, et al. Permeable cryoprotectants-free vitrification of human TESE, PESA and OAT spermatozoa: clinical outcomes. Systems Biology in Reproductive Medicine. 2025;71(1):54–60.
Liu S, et al. Cryopreservation of single-sperm from semen and testicular samples: a five-year monocentric experience in hundreds of patients. Reproductive Biology and Endocrinology. 2026;24(1):28.
Li YX, et al. Vitrification and conventional freezing methods in sperm cryopreservation: a systematic review and meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2019;233:84–92.